In response to the large number of lawsuits and reports of serious complications from various medical implants, including reported Zimmer knee problems from NexGen CR-Flex knee implants, FDA has proposed a new regulation that would require all new medical devices to have unique device identifiers,... Read More

In the United States in 2011, there were 2,367 reports of Pradaxa hemorrhage, as well as 542 reports of Pradaxa deaths. The manufacturer Boehringer Ingelheim first introduced the anticoagulant drug on the market in 2010 as a superior alternative to Coumadin (also known as warfarin).... Read More

Early clinical studies showed sexual side effects from Propecia (finasteride) included decreased libido (1.8 percent of users); erectile problems from Propecia (1.3 percent of users); and decreased ejaculate (1.2 percent of users). In 2011, the Boston University School of Medicine found these side effects were... Read More

Originally approved by the FDA in 2004, the American Medical Systems (AMS) transvaginal mesh system is sold to assist women who have experienced vaginal vault prolapse, stress urinary incontinence (transvaginal mesh implant to treat SUI), and pelvic organ prolapse, which tend to occur as a... Read More

Following an FDA safety announcement regarding Actos in summer 2011, the French Medicines Agency suspended sales of the drug and, later that summer, manufacturer Takeda implemented a recall of Actos in France. It was about that time that patients began seeking legal advice in an... Read More

An Illinois resident filed a lawsuit regarding side effects of the clot-busting drug Pradaxa in the United States' District Court for the Southern District of Illinois recently. Jacqueline Boston filed her lawsuit on May 11, 2012, claiming that drug maker Boehringer Ingelheim Pharmaceuticals is liable... Read More

Zoloft (sertraline) is an antidepressant medication of the type known as selective serotonin reuptake inhibitors, or “SSRIs”. A developing infant exposed to sertraline in the womb may be born with a range of debilitating conditions such as heart problems after taking Zoloft, persistent pulmonary hypertension... Read More

To improve their ability to follow-up on medical devices after they’ve been released on the market and to create prompter recalls when necessary, the FDA proposed a plan to create a new system that would assign a unique identification number to each high-risk medical device.... Read More